ArticleCritical care (London, England)2019

Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes.

Daisuke Hasegawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.